Health
Moscow/Sputnik: The US Food and Drug Administration (FDA) has approved the antiviral drug remdesivir as the first COVID-19 treatment without having taken into consideration the results of the World Health Organization's (WHO) Solidarity Trial, Soumya Swaminathan, the WHO's chief scientist, said on Friday. more
WHO study shows Remdesivir has little effect in reducing COVID-19 mortality: Reports
Moscow/Sputnik: The antiviral drug remdesivir, which has been touted as a treatment for COVID-19, appears to have no substantial effect in reducing patient mortality, according to a fresh ...
Remdesivir drug helps moderately ill COVID-19 patients, says Gilead
California: California-based biotech company Gilead Sciences, Inc on Monday announced topline results from the Phase 3 SIMPLE trial in hospitalized patients with moderate COVID-19 pneumon ...
